Akèy › Oligodendrogliom
Etid klinik pou Oligodendrogliom ap rekrite nan Etazini
15 etid pou Oligodendrogliom ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Ap rekriteFaz 1
Laj 19 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05698524SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Ap rekriteFaz 1/2
Laj 2 a 24 · Tout sèks · Mizajou Sep 11, 2026 · NCT04923126FearLess in NeuroOncology
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06989086HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388Study of Olutasidenib and Temozolomide in HGG
Ap rekriteFaz 2
Laj 12 a 39 · Tout sèks · Mizajou Sep 1, 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT04623931Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT07468136ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients
Ap rekriteFaz 1
Laj 18 a 89 · Tout sèks · Mizajou May 27, 2026 · NCT06254326Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 21, 2026 · NCT07462507All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 20, 2026 · NCT05345002Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT04541082Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 1 a 21 · Tout sèks · Mizajou Dec 8, 2025 · NCT05956821HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT06930846Implantable Microdevice In Primary Brain Tumors
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2025 · NCT04135807Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.